CD274 and lung carcinoma: Altogether, the results of this validation study propose that the analysis of dynamic levels of PD-L1 in EVs could be used as a predictive model to identify patients with advanced lung cancer who would derive benefit from ICIs and present better outcomes, potentially substituting or complementing the standard-of-care tissue PD-L1.